[
  {
    "ts": null,
    "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
    "summary": "TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.",
    "url": "https://finnhub.io/api/news?id=99abf4a7b84da6680b896cad93befd9312a9c5cb25066aa2b1ae53ce2f478f16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756484640,
      "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
      "id": 136573897,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.",
      "url": "https://finnhub.io/api/news?id=99abf4a7b84da6680b896cad93befd9312a9c5cb25066aa2b1ae53ce2f478f16"
    }
  },
  {
    "ts": null,
    "headline": "COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down",
    "summary": "Cooper Companies beats on Q3 earnings with 15% EPS growth, but revenue weakness and a trimmed 2025 outlook send shares tumbling.",
    "url": "https://finnhub.io/api/news?id=ecc3f7ddefab4a8fdb8e53df96008ccec029088233a7a4da70bb28fa2e01f61e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756475220,
      "headline": "COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down",
      "id": 136569342,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Cooper Companies beats on Q3 earnings with 15% EPS growth, but revenue weakness and a trimmed 2025 outlook send shares tumbling.",
      "url": "https://finnhub.io/api/news?id=ecc3f7ddefab4a8fdb8e53df96008ccec029088233a7a4da70bb28fa2e01f61e"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add CLOV Stock to Your Portfolio Now",
    "summary": "Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.",
    "url": "https://finnhub.io/api/news?id=a244edb5e65caad42492f3824ee7c3eb81f18ac8ec8b5452ad7a34e7d31b3c2a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756475220,
      "headline": "Here's Why You Should Add CLOV Stock to Your Portfolio Now",
      "id": 136569341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Clover's strong membership growth, rising revenues, and first-half EBITDA profitability highlight its tech-driven Medicare Advantage edge.",
      "url": "https://finnhub.io/api/news?id=a244edb5e65caad42492f3824ee7c3eb81f18ac8ec8b5452ad7a34e7d31b3c2a"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Boston Scientific (BSX) This Year?",
    "summary": "Here is how Boston Scientific (BSX) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=c4addebaf7b8826cd8dd89f6878c4af15214b1625ccabf1a8409142aabf547d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756474802,
      "headline": "Are Medical Stocks Lagging  Boston Scientific (BSX) This Year?",
      "id": 136569343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Here is how Boston Scientific (BSX) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=c4addebaf7b8826cd8dd89f6878c4af15214b1625ccabf1a8409142aabf547d4"
    }
  },
  {
    "ts": null,
    "headline": "The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?",
    "summary": "HOLX fuels growth with targeted M&A across Diagnostics, Breast Health, and GYN Surgical, backed by a strong balance sheet.",
    "url": "https://finnhub.io/api/news?id=d7a12b86ba2f5632ddd203a7cdff7f1f1ba7144415a4a9a7331ffa5db6c54900",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756469160,
      "headline": "The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?",
      "id": 136569344,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HOLX fuels growth with targeted M&A across Diagnostics, Breast Health, and GYN Surgical, backed by a strong balance sheet.",
      "url": "https://finnhub.io/api/news?id=d7a12b86ba2f5632ddd203a7cdff7f1f1ba7144415a4a9a7331ffa5db6c54900"
    }
  },
  {
    "ts": null,
    "headline": "Is your AI bet too big? How to balance with other growth themes",
    "summary": "Investors heavily exposed to artificial intelligence (AI) may want to think about where else to put their money as markets shift. Drew Pettit, Citi US equity strategist, explains how fintech and wearable tech could balance out investor portfolios. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
    "url": "https://finnhub.io/api/news?id=10cf4b5d5f68a46c6de6c918e8a26eeb2818765852801fe4ea5bd5f3612d353b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756465207,
      "headline": "Is your AI bet too big? How to balance with other growth themes",
      "id": 136569330,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investors heavily exposed to artificial intelligence (AI) may want to think about where else to put their money as markets shift. Drew Pettit, Citi US equity strategist, explains how fintech and wearable tech could balance out investor portfolios. To watch more expert insights and analysis on the latest market action, check out more Market Domination.",
      "url": "https://finnhub.io/api/news?id=10cf4b5d5f68a46c6de6c918e8a26eeb2818765852801fe4ea5bd5f3612d353b"
    }
  }
]